Limocitrin 3-β-D-glucose

Catalog No. :
ACWZPF617
CAS No. :
38836-51-0
Molecular Formula :
C23H24O13
Molecular Weight :
508.43

IUPAC Name:5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

Limocitrin 3-β-D-glucose structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$267.00Login to see priceInquiryInquiry
5mg98%$804.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameLimocitrin 3-β-D-glucose
IUPAC Name5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
Molecular FormulaC23H24O13
Molecular Weight508.43
SMILESO=C1C(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)=C(C3=CC=C(O)C(OC)=C3)OC4=C1C(O)=CC(O)=C4OC
InChI KeyXZGXHUKLGCOGII-FTVHLUNLSA-N
SynonymLimocitrin 3-O-β-D-glucopyranoside;Limocitrin 3-β-D-glucose;Limocitrin 3-O-beta-D-glucopyranoside;4H-1-Benzopyran-4-one, 3-(β-D-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methoxy-
CAS No.38836-51-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWZPF617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZPF617 route product structure diagram
    ACWZPF61738836-51-0
Inquiry

2. ACWZPF617 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWZPF617 route product structure diagram
    ACWZPF61738836-51-0
Inquiry

Comments (0)